UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Is serum‐derived exosomal hTERT transcript a marker of oncogenic activity in primary brain tumors? An exploratory study

Cancer medicine (Malden, MA), 2024-01, Vol.13 (1), p.e6784-n/a

2024

Volltextzugriff (PDF)

Breast cancer and leptomeningeal disease (LMD): hormone receptor status influences time to development of LMD and survival from LMD diagnosis

Journal of neuro-oncology, 2013-09, Vol.114 (2), p.229-235

2013

Volltextzugriff (PDF)

Mechanisms of post-radiation injury: cerebral microinfarction not a significant factor

Journal of neuro-oncology, 2017, Vol.131 (2), p.277-281

2017

Volltextzugriff (PDF)

182P Intracranial response to nivolumab in NSCLC patients with untreated or progressing CNS metastases

Journal of thoracic oncology, 2016-04, Vol.11 (4), p.S136-S137

2016

Volltextzugriff (PDF)

The effect of duloxetine on primary pain symptoms in Parkinson disease

Clinical neuropharmacology, 2007-07, Vol.30 (4), p.201-205

2007

Volltextzugriff (PDF)

Vorasidenib in IDH1- or IDH2-Mutant Low-Grade Glioma

The New England journal of medicine, 2023-08, Vol.389 (7), p.589-601

2023

Volltextzugriff (PDF)

EP09.04-03 Survival of Non-small Cell Lung Cancer with and without Brain Metastasis - Shifting to a Merging Survival Curves Era

Journal of thoracic oncology, 2023-11, Vol.18 (11), p.S599-S600

2023

Volltextzugriff (PDF)

Clinical characteristics of Parkinson's disease among Jewish Ethnic groups in Israel

Journal of Neural Transmission, 2008-09, Vol.115 (9), p.1279-1284

2008

Volltextzugriff (PDF)

KS03.5.A COMPARING VOLUMETRIC GROWTH-RATE AND RANO CRITERIA IN DETERMINING THE RESPONSE OF MENINGIOMA TO BEVACIZUMAB THERAPY

Neuro-oncology (Charlottesville, Va.), 2023-09, Vol.25 (Supplement_2), p.ii5-ii5

2023

Volltextzugriff (PDF)

P11.70.A The yield of screening brain MRI among stage IV non small cell lung cancer patients

Neuro-oncology (Charlottesville, Va.), 2022-09, Vol.24 (Supplement_2), p.ii74-ii75

2022

Volltextzugriff (PDF)

Pain in Extrapyramidal Neurodegenerative Diseases

The Clinical journal of pain, 2017-07, Vol.33 (7), p.635-639

2017

Volltextzugriff (PDF)

P12.01.B Systemic metabolic features associated with significant insulin resistance in diabetes mellitus type 2 patients are related to the presence of gemistocytes in glioblastoma

Neuro-oncology (Charlottesville, Va.), 2022-09, Vol.24 (Supplement_2), p.ii76-ii77

2022

Volltextzugriff (PDF)

P01.104 Evaluation of high signal intensity in globus pallidus and dentate nucleus on unenhanced T1-weighted images after administration of Dotarem vs. Gadavist in brain tumor patients who undergo multiple MRI evaluations

Neuro-oncology (Charlottesville, Va.), 2018-09, Vol.20 (suppl_3), p.iii255-iii255

2018

Volltextzugriff (PDF)

P14.09.B IS BLOOD-DERIVED EXOSOMAL HTERT TRANSCRIPT A MARKER OF ONCOGENIC ACTIVITY IN PRIMARY BRAIN TUMORS? AN EXPLORATORY STUDY

Neuro-oncology (Charlottesville, Va.), 2023-09, Vol.25 (Supplement_2), p.ii107-ii107

2023

Volltextzugriff (PDF)

P05.04 Phase 2 open-label study of maintenance treatment with ibrutinib following first line methotrexate-based immuno-chemotherapy in elderly patients with primary CNS lymphoma (PCNSL)

Neuro-oncology (Charlottesville, Va.), 2019-09, Vol.21 (Supplement_3), p.iii34-iii34

2019

Volltextzugriff (PDF)

P14.72 Multicentric glioblastoma - A retrospective study of imaging characteristics, treatment approach, pattern of relapse and survival

Neuro-oncology (Charlottesville, Va.), 2019-09, Vol.21 (Supplement_3), p.iii84-iii84

2019

Volltextzugriff (PDF)

OS05.2 Burnout and Career Satisfaction among Neuro-Oncology Health Care Providers: An International Survey

Neuro-oncology (Charlottesville, Va.), 2017-05, Vol.19 (suppl_3), p.iii9-iii9

2017

Volltextzugriff (PDF)

Osimertinib for patients with EGFR-mutant advanced NSCLC and asymptomatic brain metastases: An open-label, two-arm, phase II study

Annals of oncology, 2019-11, Vol.30, p.ix177-ix178

2019

Volltextzugriff (PDF)

P05.77 Echoes from the past- an historical cohort study of low dose radiation for tinea capitis and brain tumor incidence in Israel

Neuro-oncology (Charlottesville, Va.), 2018-09, Vol.20 (suppl_3), p.iii321-iii321

2018

Volltextzugriff (PDF)

P09.06 Risk factors associated with Meningioma in a Cohort of 2 Million Israeli Adolescents

Neuro-oncology (Charlottesville, Va.), 2019-09, Vol.21 (Supplement_3), p.iii39-iii40

2019

Volltextzugriff (PDF)

PO-94 Intracranial hemorrhage with direct oral anticoagulants in patients with primary or secondary brain tumors

Thrombosis research, 2021-04, Vol.200, p.S70-S71

2021

Volltextzugriff (PDF)

P2.12-14 Stereotactic Radiosurgery for Brain Metastases in Small Cell Lung Cancer

Journal of thoracic oncology, 2018-10, Vol.13 (10), p.S796-S796

2018

Volltextzugriff (PDF)

A.6 INDIGO: a global, randomized, double-blinded, Phase 3 study of vorasidenib versus placebo in patients with grade 2 glioma with an IDH1/2 mutation (mIDH1/2)

Canadian journal of neurological sciences, 2024-06, Vol.51 (s1), p.S4-S4

2024

Volltextzugriff (PDF)

P13.10 Intracranial response to nivolumab in NSCLC patients with untreated or progressing CNS metastases

Neuro-oncology (Charlottesville, Va.), 2016-10, Vol.18 (suppl_4), p.iv71-iv71

2016

Volltextzugriff (PDF)

P07.13 Aberrant paramagnetic/diamagnetic MRI signals outside the tumor volume are frequent findings that evolve overtime in adult patients surviving two or more years after brain irradiation

Neuro-oncology (Charlottesville, Va.), 2016-10, Vol.18 (suppl_4), p.iv36-iv37

2016

Volltextzugriff (PDF)

1 – 25 von 137

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(126)
Mit Volltextzugriff
(123)

Publikationsform

Artikel
(133)
Buchkapitel
(4)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Is serum‐derived exosomal hTERT transcript a marker of oncogenic activity in primary brain tumors? An exploratory study

Breast cancer and leptomeningeal disease (LMD): hormone receptor status influences time to development of LMD and survival from LMD diagnosis

Mechanisms of post-radiation injury: cerebral microinfarction not a significant factor

182P Intracranial response to nivolumab in NSCLC patients with untreated or progressing CNS metastases

The effect of duloxetine on primary pain symptoms in Parkinson disease

Vorasidenib in IDH1- or IDH2-Mutant Low-Grade Glioma

EP09.04-03 Survival of Non-small Cell Lung Cancer with and without Brain Metastasis - Shifting to a Merging Survival Curves Era

Clinical characteristics of Parkinson's disease among Jewish Ethnic groups in Israel

KS03.5.A COMPARING VOLUMETRIC GROWTH-RATE AND RANO CRITERIA IN DETERMINING THE RESPONSE OF MENINGIOMA TO BEVACIZUMAB THERAPY

P11.70.A The yield of screening brain MRI among stage IV non small cell lung cancer patients

Pain in Extrapyramidal Neurodegenerative Diseases

P12.01.B Systemic metabolic features associated with significant insulin resistance in diabetes mellitus type 2 patients are related to the presence of gemistocytes in glioblastoma

P01.104 Evaluation of high signal intensity in globus pallidus and dentate nucleus on unenhanced T1-weighted images after administration of Dotarem vs. Gadavist in brain tumor patients who undergo multiple MRI evaluations

P14.09.B IS BLOOD-DERIVED EXOSOMAL HTERT TRANSCRIPT A MARKER OF ONCOGENIC ACTIVITY IN PRIMARY BRAIN TUMORS? AN EXPLORATORY STUDY

P05.04 Phase 2 open-label study of maintenance treatment with ibrutinib following first line methotrexate-based immuno-chemotherapy in elderly patients with primary CNS lymphoma (PCNSL)

P14.72 Multicentric glioblastoma - A retrospective study of imaging characteristics, treatment approach, pattern of relapse and survival

OS05.2 Burnout and Career Satisfaction among Neuro-Oncology Health Care Providers: An International Survey

Osimertinib for patients with EGFR-mutant advanced NSCLC and asymptomatic brain metastases: An open-label, two-arm, phase II study

P05.77 Echoes from the past- an historical cohort study of low dose radiation for tinea capitis and brain tumor incidence in Israel

P09.06 Risk factors associated with Meningioma in a Cohort of 2 Million Israeli Adolescents

PO-94 Intracranial hemorrhage with direct oral anticoagulants in patients with primary or secondary brain tumors

P2.12-14 Stereotactic Radiosurgery for Brain Metastases in Small Cell Lung Cancer

A.6 INDIGO: a global, randomized, double-blinded, Phase 3 study of vorasidenib versus placebo in patients with grade 2 glioma with an IDH1/2 mutation (mIDH1/2)

P13.10 Intracranial response to nivolumab in NSCLC patients with untreated or progressing CNS metastases

P07.13 Aberrant paramagnetic/diamagnetic MRI signals outside the tumor volume are frequent findings that evolve overtime in adult patients surviving two or more years after brain irradiation

Suchergebnisse filtern